カナダ - 英語 - Health Canada

sandoz canada incorporated - rivastigmine - patch - 9.5mg - rivastigmine 9.5mg - parasympathomemetic (cholinergic) agents

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

dolgencorp inc - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - menthol 750 mg - uses for temporary relief of minor aches and pains of muscles and joints associated with - arthritis - simple backache - bursitis - tendonitis - muscle strains - muscle sprains - bruises - cramps stop use and ask a doctor - condition worsens - redness is present - irritation develops - symptoms persist for more than 7 days or clear up and occur again within a few days directions adults and children over 12 years: - remove backing from patch by grasping both ends firmly and gently pulling until backing separates in middle - carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area - once exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affected area - apply one patch to affected area - wear one patch up to 8 hours - repeat as necessary, but no more than 3 time daily children 12 years or younger: ask a doctor

フィリピン - 英語 - FDA (Food And Drug Administration)

ambica international trading corporation; distributor: atc healthcare international corp. - atorvastatin (as calcium) - film-coated tablet - 20 mg

フィリピン - 英語 - FDA (Food And Drug Administration)

ambica international corporation; distributor: atc healthcare international corp. - atorvastatin (as calcium) - film-coated tablet - 40 mg

フィリピン - 英語 - FDA (Food And Drug Administration)

ambica international trading corp.; distributor: atc healthcare international corp. - pantoprazole (as sodium sesquihydrate) - enteric-coated tablet - 40mg

フィリピン - 英語 - FDA (Food And Drug Administration)

atc healthcare international corp - pioglitazone hydrochloride - tablet - 30mg

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - rivastigmine 18mg;   - transdermal patch - 9.5 mg/24h - active: rivastigmine 18mg   excipient: acrylates copolymer acrylic adhesive fluoro-coated polyester release liner (22.5 cm2/patch) silicone adhesive - treatment of patients with: · mild to moderately severe dementia of the alzheimer's type (also termed probable alzheimer's disease or alzheimer's disease) · severe dementia of the alzheimer's type.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - rivastigmine 27mg;   - transdermal patch - 13.3 mg/24h - active: rivastigmine 27mg   excipient: acrylates copolymer acrylic adhesive fluoro-coated polyester release liner (33 cm2/patch) silicone adhesive - treatment of patients with: · mild to moderately severe dementia of the alzheimer's type (also termed probable alzheimer's disease or alzheimer's disease) · severe dementia of the alzheimer's type.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - rivastigmine 9mg;   - transdermal patch - 4.6 mg/24h - active: rivastigmine 9mg   excipient: acrylates copolymer acrylic adhesive fluoro-coated polyester release liner (14 cm2/patch) silicone adhesive - treatment of patients with: · mild to moderately severe dementia of the alzheimer's type (also termed probable alzheimer's disease or alzheimer's disease) · severe dementia of the alzheimer's type.

イスラエル - 英語 - Ministry of Health

novartis israel ltd - rivastigmine - patches - rivastigmine 9.5 mg/day - rivastigmine - treatment of mild to moderate dementia of the alzheimer's type.